Clinical Trial Update: Safety Study of ON 01910.Na in Combination With Irinotecan or Oxaliplatin [Phase 1]

View source ↗

Summary

Phase 1 safety study of ON 01910.Na in combination with irinotecan or oxaliplatin for advanced solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• ON-01910.Na (ON-01910 sodium)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Traws Pharma, Inc. | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED